Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_assertion type Assertion NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_head.
- NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_assertion wasGeneratedBy ECO_0000203 NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_provenance.
- NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_assertion wasDerivedFrom befree-20150227 NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_provenance.
- NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_assertion SIO_000772 22447153 NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_provenance.
- NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_assertion evidence source_evidence_literature NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_provenance.
- NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_assertion description "[In this paper we demonstrate that bezafibrate, a PPAR pan agonist used for the treatment of patients with hyperlipidaemia reduces VLCFA levels in X-ALD fibroblasts.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636433.RATD1YY1EXlhUqxQZd_8f9VSKWMU-7gc5rJs9FCMGx6Iw130_provenance.